TRAF1 and metabolic dysfunction-associated steatotic liver disease: Increased TRAF1 expression in the livers of NAFLD patients and TRAF1 overexpression in hepatocytes contributes to the development of insulin resistance, inflammatory response and hepatic steatosis.